MiRNA-194 regulates palmitic acid-induced toll-like receptor 4 inflammatory responses in THP-1 cells

Nutrients

Volumn 7, Issue 5, 2015, Pages 3483-3496

  Tian, Huiqun ^a   Liu, Chaoqi ^a   Zou, Xiaohua ^a   Wu, Wei ^a   Zhang, Changcheng ^a   Yuan, Ding ^a  

^a CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

miR 194; Palmitic acid; TLR4; TRAF6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 194; PALMITIC ACID; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FATTY ACID; MIRN194 MICRORNA, HUMAN; RECOMBINANT PROTEIN; TLR4 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWNREGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; LUCIFERASE ASSAY; METABOLIC REGULATION; MONOCYTE CULTURE; OBESITY; PLASMID; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; AGONISTS; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MONOCYTE; OSMOLARITY; REPORTER GENE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; CELL LINE; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICRORNAS; MONOCYTES; OSMOLAR CONCENTRATION; PALMITIC ACID; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929376528     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7053483     Document Type: Article

References (33)

1. Xu, J. M.; Shi, G. P. Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr. Rev. 2012, 33, 71-108.
2. Odegaard, J. I.; Ricardo-Gonzalez, R. R.; Red Eagle, A.; Vats, D.; Morel, C. R.; Gogorth, M. H.; Subramanian, V.; Mukundan, L.; Ferrante, A. W.; Chawla, A.; et al. Alternative M2 activation of Kupffer cells by PPARδameliorates obesity-induced insulin resistance. Cell Metab. 2008, 7, 496-507.
3. Liu, R.-M.; Gaston Pravia, K. A. Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic. Biol. Med. 2010, 48, 1-15.
4. Muraille, E.; Leo, O.; Moser, M. TH1/TH2 paradigm extended: Macrophage polarization as an unappreciated pathogen-driven escape mechanism. Front. Immunol. 2014, 5, 603, doi: 10. 3389/fimmu. 2014. 00603.
5. Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30, 16-34.
6. Moghimpour Bijani, F.; Vallejo, J. G.; Rezaei, N. Toll-like receptor signaling pathways in cardiovascular disease: Challenges and opportunities. Int. Rev. Immunol. 2012, 31, 379-395.
7. Lumeng, C. N.; Bodzin Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 2007, 117, 175-184.
8. Lee, J. Y.; Sohn, K. H.; Rhee, S. H.; Hwang, D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276, 16683-16689.
9. Suganami, T.; Ogawa, Y. Adipose tissue macrophages: Their role in adipose tissue remodeling. J. Leukoc. Biol. 2010, 88, 33-39.
10. Liu, S. P.; Li, X. Y.; Li, Z.; He, L. N.; Xiao, Y.; Yan, K.; Zhou, Z. G. Octanoylated Ghrelin Inhibits the Activation of the Palmitic Acid-Induced TLR4/NF-κB Signaling Pathway in THP-1 Macrophages. ISRN Endocrinol. 2012, 2012, 237613, doi: 10. 5402/2012/237613.
11. Rivera, C. A.; Adegboyega, P.; van Rooijen, N.; Tagalicud, A.; Allman, M.; Wallace, M. Toll-like receptor-4 signaling and Kupffer cells play privotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 2007, 47, 571-579.
12. Tsukumo, D. M.; Carvalho, M. A.; Carvalherira, J. B.; Prada, P. O.; Hirabara, S. M.; Schenka, A. A.; Araujo, E. P.; Vassallo, J.; Curi, R.; Velloso, L. A.; et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56, 1986-1998.
13. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455, 58-63.
14. Friedman, R. C.; Farh, K. K.; Burge, C. B.; Bartel, D. P. Moat mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19, 92-105.
15. Jiang, W.; Kong, L.; Ni, Q.; Lu, Y.; Ding, W.; Liu, G.; Pu, L.; Tang, W.; Kong, L. miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1and TRAF6. PLoS ONE 2014, 2, e101530.
16. Fessler, M. B.; Rudel, L. L.; Brown, J. M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr. Opin. Lipidol. 2009, 20, 379-385.
17. Aalaei-andabili, S. H.; Nima, R. Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) and immune response against infection: A systematic review. J. Infect. 2013, 67, 251-264.
18. Beillard, E.; Ong, S. C.; Giannakakis, A.; Guccione, E.; Vardy, L. A.; Voorhoeve, P. M. miR-Sens-a retroviral dual-luciferase reporter to detect microRNA activity in primary cells. RNA 2012, 18, 1091-1100.
19. Takeda, K.; Akira, S. TLR signaling pathways. Semin. Immunol. 2004, 16, 3-9.
20. Ghanim, H.; Aljada, A.; Hofmeyer, D.; Syed, T.; Mohanty, P.; Dandona, P. Circulating monounuclear cells in the obese are in a proinflammatory state. Circulation 2004, 110, 1564-1571.
21. Dandona, P.; Aljiada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25, 4-7.
22. Kumar, H.; Kawai, T.; Akira, S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 2009, 388, 621-625.
23. Leroux, A.; Ferrere, G.; Godie, V.; Cailleux, F.; Renoud, M. L.; Gaudin, F.; Naveau, S.; Prevot, S.; Makhzami, S.; Perlemuter, G.; et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J. Hepatol. 2012, 57, 141-149.
24. Henao-Mejia, J.; Elinav, E.; Jin, C.; Hao, L.; Mehal, W. Z.; Strowig, T.; Thaiss, C. A.; Kau, A. L.; Eisenbarth, S. C.; Jurczak, M. J.; et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482, 179-185.
25. Miura, K.; Seki, E.; Ohnishi, H.; Brenner, D. A. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol. Res. Pract. 2010, 2010, 362847, doi: 10. 1155/2010/362847.
26. Roh, Y. S.; Seki, E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J. Gastroenterol. Hepatol. 2013, 28, 38-42.
27. Suganami, T.; Nishida, J.; Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2062-2068.
28. De Pablo, M. A.; de Cienfuegos, G. A. Modulatory effects of dietary lipids on immune system function. Immunol. Cell Biol. 2000, 78, 31-39.
29. Bhattacharyya, S.; Kelley, K.; Melichian, D. S.; Tamaki, Z.; Fang, F.; Su, Y.; Feng, G.; Pope, R. M.; Budinger, G. R.; Mutlu, G. M.; et al. Toll-like receptor 4 signaling augments transforming growth factor-β responses: A novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 2013, 182, 192-205.
30. Baffy, G. Kupffer cells in non-alcoholic fatty liver disease: The emerging view. J. Hepatol. 2009, 51, 212-223.
31. Venugopal, S. K.; Jiang, J.; Kim, T. H.; Li, Y.; Wang, S. S.; Torok, N. J.; Zern, M. A. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G101-G106.
32. Duffield, J. S.; Forbes, S. J.; Constandinou, C. M.; Clay, S.; Partolina, M.; Vuthoori, S.; Wu, S.; Lang, R.; Iredale, J. P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Investig. 2005, 115, 56-65.
33. Seki, E.; de Minicis, S.; Osterreicher, C. H.; Kluwe, J.; Osawa, Y.; Brenner, D. A.; Schwabe, R. F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13, 1324-1332.